HomeLVTX • NASDAQ
add
LAVA Therapeutics NV
Previous close
$1.24
Day range
$1.21 - $1.28
Year range
$0.85 - $2.81
Market cap
32.88M USD
Avg Volume
51.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.59M | -15.16% |
Net income | -3.48M | -529.11% |
Net profit margin | — | — |
Earnings per share | -0.12 | -531.65% |
EBITDA | -7.47M | -313.23% |
Effective tax rate | -6.91% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 66.56M | -29.62% |
Total assets | 71.16M | -28.18% |
Total liabilities | 45.37M | -6.28% |
Total equity | 25.78M | — |
Shares outstanding | 26.89M | — |
Price to book | 1.29 | — |
Return on assets | -24.96% | — |
Return on capital | -64.17% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.48M | -529.11% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2016
Website
Employees
34
